DUBLIN--(BUSINESS WIRE)--Aug 29, 2018--The "Transradial Access Devices Market by Product, by Application, by End User, by Geography - Global Market Size, Share, Development, Growth, and Demand Forecast, 2013 - 2023" report has been added to ResearchAndMarkets.com's offering.

Global transradial access devices market size is forecasted to reach $24.1 billion by 2023.

The cost-benefit associated with transradial artery access, increasing preference of radial artery access for interventional procedures, increasing prevalence of chronic diseases, increasing number of chemotherapy procedures, growing use of radial access devices in geriatric as well as high risk patients, and rising healthcare expenditure are the key factors driving the growth of the transradial access market.

On the basis of product, the transradial access devices market has been categorized into catheters, guidewires, sheaths and sheath introducers, and accessories. Of these, the fastest growth during the forecast period is expected from catheters, with 9.0% CAGR. This is mainly attributed to the adoption of miniaturized diagnostic catheters such as 4F and 5F catheters.

Among all applications of transradial access devices, drug administration is expected to be the fastest growing category, with CAGR of 8.9% during the forecast period. This can be attributed to the increased use of vascular access devices over others. On the basis of end user, hospitals have been the dominant category, with a share of 76.4% in 2017. This can be ascribed to the large patient base being treated with transradial access approach and the increasing number of procedures being conducted in cath labs in hospitals.

Market Dynamics


Collaborations With Medical Device Reprocessing Players Increasing Focus On Development Of Robotic-Assisted Catheter Systems Growing Focus Of Market Players On Emerging Economies


Cost-Benefit Associated With Transradial Artery Access Increasing Preference Of Radial Artery Access For Interventional Procedures Increasing Prevalence Of Chronic Diseases Increasing Number Of Chemotherapy Procedures Growing Use Of Radial Access Devices In Geriatric As Well As High Risk Patients Rising Healthcare Expenditure


Dearth Of Highly Skilled Professionals Product Recalls And Failures


Technological Advancements In Transradial Access Devices Increasing Acquisition And Collaboration Between Players

Company Profiles

Terumo Corporation Becton, Dickinson And Company Medtronic Plc Smith Group Plc Edwards Lifesciences Corporation Angiodynamics Inc. Merit Medical Systems Inc. Teleflex Incorporated Nipro Corporation Boston Scientific Corporation

For more information about this report visit https://www.researchandmarkets.com/research/8l3h8m/transradial?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180829005286/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Surgical Devices



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/29/2018 05:57 AM/DISC: 08/29/2018 05:57 AM